-
Johnson & Johnson settlement will be over $6.4B for ovarian cancer lawsuitsMay 1, 2024 -
J&J to end global sales of talc-based powder amid lawsuits, cancer concernsAugust 12, 2022 -
FDA limits use of Johnson & Johnson COVID-19 vaccine due to risk of blood clotsMay 5, 2022 -
Refusal to receive COVID-19 vaccine remains hot button issue within the Chicago Police DepartmentApril 14, 2022 -
If you're over 50, here's why you may not want to rush to get another boosterMarch 31, 2022 -
Illinois to receive $760M settlement from pharmaceutical companies to fight opioid crisisFebruary 25, 2022 -
Native American tribes to receive $590 million in opioid caseFebruary 3, 2022 -
Who will be eligible this week for a 4th COVID shot?January 12, 2022 -
Blood clot issues with J&J vaccine connected to at least 9 deathsDecember 17, 2021 -
J&J vaccine may work best as a Pfizer booster, new study showsDecember 6, 2021